{"id":178,"date":"2019-10-19T23:35:43","date_gmt":"2019-10-19T23:35:43","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/4-15-alpha-and-beta-receptor-agonists-catecholamines\/"},"modified":"2025-01-16T22:29:15","modified_gmt":"2025-01-16T22:29:15","slug":"4-15-alpha-and-beta-receptor-agonists-catecholamines","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/4-15-alpha-and-beta-receptor-agonists-catecholamines\/","title":{"raw":"4.15 Alpha- and Beta-Receptor Agonists (Catecholamines)","rendered":"4.15 Alpha- and Beta-Receptor Agonists (Catecholamines)"},"content":{"raw":"<h2>Epinephrine and Norepinephrine<\/h2>\n<a id=\"_z5ionxmmm8dy\" href=\"\"><\/a>Epinephrine and norepinephrine (NE) are adrenergics (also referred to as <strong>[pb_glossary id=\"636\"]<\/strong>catecholamines<strong>[\/pb_glossary]<\/strong>) that stimulate the beta- and alpha-receptors on the target cell.\n\n<strong>Mechanism of Action:<\/strong> Epinephrine acts on both alpha- and beta-adrenergic receptors and is used in several routes, including intravenously (IV), subcutaneously, intramuscularly, and inhalation. Epinephrine decreases vasodilation and increases vascular permeability through its alpha-adrenergic receptor action, which can lead to loss of intravascular fluid volume and hypotension. Through its action on beta-adrenergic receptors, epinephrine causes bronchial smooth muscle relaxation and helps alleviate bronchospasm, wheezing, and dyspnea that may occur during anaphylaxis.\n\n<strong>Indications:<\/strong> Epinephrine is used for severe allergic reactions, acute bronchospasm during asthma attacks, cardiac resuscitation, hypotension in severe shock, or for local injection to control superficial bleeding.\n\nNorepinephrine is used as a peripheral vasoconstrictor (due to alpha-adrenergic action) and as an inotropic stimulator of the heart and dilator of coronary arteries (due to beta-adrenergic action) in clients with critically low blood pressure.\n\n<strong>Nursing Considerations:<\/strong> Epinephrine is contraindicated for use in fingers, toes, ears, nose, or genitalia when used with local anesthetic due to the vasoconstrictive action. It is also contraindicated in clients with narrow angle glaucoma. Administer with caution to the elderly and those with preexisting cardiovascular disease. Discard IV solution if discolored. When administering IV, monitor vitals (blood pressure, heart rate, and respiratory rate) and cardiovascular and respiratory systems closely; if blood pressure increases sharply, give rapid-acting vasodilators. Monitor IV site for extravasation. If extravasation occurs, immediately stop IV administration and follow agency policy. Phentolamine, an alpha-adrenergic antagonist, is the reversal agent used to reverse local vasoconstrictive effects if digital ischemia occurs.\n\n<strong>Side Effects\/Adverse Effects: <\/strong>Common side effects include hypertension and tachycardia.\n\n<strong>Health Teaching &amp; Health Promotion:<\/strong> Epinephrine formulated in a pen for injection is known as an EpiPen. An EpiPen is used for severe allergic reactions after exposure to an allergen such as a bee sting. Check expiration date, store at room temperature, and protect from light. Effects fade after 15-20 minutes, so seek medical care immediately.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\n\nNow let's take a closer look at the medication grid on epinephrine and norepinephrine in Table 4.15a.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>.[\/footnote]<\/sup>\n\nTable 4.15a Epinephrine and Norepinephrine Medication Grid\n<table class=\"grid\" style=\"height: 244px\" border=\"0\">\n<tbody>\n<tr style=\"height: 96px\">\n<th class=\"shaded\" style=\"height: 96px;width: 122.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 154.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 411.063px\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 515.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 98.0625px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr style=\"height: 147px\">\n<th style=\"height: 148px;width: 122.063px\" scope=\"row\">Catecholamine<\/th>\n<td style=\"height: 148px;width: 154.063px\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=353f2d30-4b74-43eb-a2ff-26d593d283f8\" target=\"_blank\" rel=\"noopener noreferrer\">epinephrine<\/a>\n\n<a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048\" target=\"_blank\" rel=\"noopener noreferrer\">norepinephrine<\/a><\/td>\n<td style=\"height: 148px;width: 411.063px\">Contraindicated for use in fingers, toes, ears, nose, or genitalia when used with local anesthetic\n\nMonitor vitals (blood pressure, heart rate, respiratory rate) and cardiovascular and respiratory systems closely when administering IV\n\nIf administering IV, monitor IV site for extravasation\n\nDiscard IV solution if discolored<\/td>\n<td style=\"height: 148px;width: 515.063px\">Reversal of severe allergic reaction, bronchodilation, increased blood pressure, cardiac resuscitation, or control of superficial bleeding<\/td>\n<td style=\"height: 148px;width: 98.0625px\">Hypertension\n\nTachycardia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Dopamine<\/h2>\nDopamine is another type of catecholamine specifically used to improve perfusion of organs, improve cardiac output, and increase blood pressure. Dopamine has dose-dependent effects on targeted arteries in the kidneys, heart, and brain.\n\n<strong>Mechanism of Action:<\/strong> In low doses, dopamine mainly stimulates dopamine receptors and dilates the renal vasculature. Moderate doses of dopamine stimulate beta-receptors for a positive inotropic effect. Higher doses also stimulate alpha-receptors, constricting blood vessels and increasing blood pressure.\n\n<strong>Indications:<\/strong> Dopamine is used to treat shock, improve perfusion to vital organs, increase cardiac output, and correct hypotension.\n\n<strong>Nursing Considerations:<\/strong> During infusion, frequently monitor blood pressure, cardiac output, urine output, and color and temperature of limbs. Dopamine can worsen cardiac ischemia and worsen chest pain for clients experiencing unstable angina or a myocardial infarction due to increased cardiac demand for oxygen. If urine flow decreases without hypotension, notify provider because dosage may need to be reduced. High doses of dopamine cause vasoconstriction and can cause adverse effects if extravasation occurs. Concurrent alpha- or beta-blockers can antagonize dopamine.\n\n<strong>Side Effects\/Adverse Effects: <\/strong>Common side effects include hypotension with low doses (due to vasodilatory effects) and hypertension in higher doses (due to vasoconstriction). Other side effects include tachycardia, palpitations, and dyspnea. Adverse effects include decreased blood flow to the extremities and decreased urine output.\n\n<strong>Health Teaching &amp; Health Promotion: <\/strong>Clients should contact their health care provider immediately if experiencing unusual sweating, dizziness, heart palpitations, or chest pain.\n\nNow let's take a closer look at the medication grid on dopamine in Table 4.15b.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>.[\/footnote]<\/sup>\n\nTable 4.15b Dopamine Medication Grid\n<table class=\"grid\" border=\"0\">\n<tbody>\n<tr>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th scope=\"row\">Catecholamine<\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">dopamine<\/a><\/td>\n<td>During infusion, monitor ECG, blood pressure, cardiac output, chest pain, pulse rate, urine output, and color and temperature of limbs\n\nCheck urine output often\n\nMonitor for extravasation. High doses of dopamine cause vasoconstriction and can cause adverse effects if extravasation occurs<\/td>\n<td>Increased blood flow to kidneys causing increased urine output in low doses\n\nIncreased cardiac output and elevated blood pressure in moderate to high doses<\/td>\n<td>Hypotension (low doses) or hypertension (high doses)\n\nTachycardia\n\nPalpitations\n\nChest pain\n\nDyspnea\n\nDecreased blood flow to extremities\n\nIf urine flow decreases without hypotension, notify provider because dosage may need to be reduced<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n&nbsp;","rendered":"<h2>Epinephrine and Norepinephrine<\/h2>\n<p><a id=\"_z5ionxmmm8dy\" href=\"\"><\/a>Epinephrine and norepinephrine (NE) are adrenergics (also referred to as <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_178_636\"><\/strong>catecholamines<strong><\/a><\/strong>) that stimulate the beta- and alpha-receptors on the target cell.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Epinephrine acts on both alpha- and beta-adrenergic receptors and is used in several routes, including intravenously (IV), subcutaneously, intramuscularly, and inhalation. Epinephrine decreases vasodilation and increases vascular permeability through its alpha-adrenergic receptor action, which can lead to loss of intravascular fluid volume and hypotension. Through its action on beta-adrenergic receptors, epinephrine causes bronchial smooth muscle relaxation and helps alleviate bronchospasm, wheezing, and dyspnea that may occur during anaphylaxis.<\/p>\n<p><strong>Indications:<\/strong> Epinephrine is used for severe allergic reactions, acute bronchospasm during asthma attacks, cardiac resuscitation, hypotension in severe shock, or for local injection to control superficial bleeding.<\/p>\n<p>Norepinephrine is used as a peripheral vasoconstrictor (due to alpha-adrenergic action) and as an inotropic stimulator of the heart and dilator of coronary arteries (due to beta-adrenergic action) in clients with critically low blood pressure.<\/p>\n<p><strong>Nursing Considerations:<\/strong> Epinephrine is contraindicated for use in fingers, toes, ears, nose, or genitalia when used with local anesthetic due to the vasoconstrictive action. It is also contraindicated in clients with narrow angle glaucoma. Administer with caution to the elderly and those with preexisting cardiovascular disease. Discard IV solution if discolored. When administering IV, monitor vitals (blood pressure, heart rate, and respiratory rate) and cardiovascular and respiratory systems closely; if blood pressure increases sharply, give rapid-acting vasodilators. Monitor IV site for extravasation. If extravasation occurs, immediately stop IV administration and follow agency policy. Phentolamine, an alpha-adrenergic antagonist, is the reversal agent used to reverse local vasoconstrictive effects if digital ischemia occurs.<\/p>\n<p><strong>Side Effects\/Adverse Effects: <\/strong>Common side effects include hypertension and tachycardia.<\/p>\n<p><strong>Health Teaching &amp; Health Promotion:<\/strong> Epinephrine formulated in a pen for injection is known as an EpiPen. An EpiPen is used for severe allergic reactions after exposure to an allergen such as a bee sting. Check expiration date, store at room temperature, and protect from light. Effects fade after 15-20 minutes, so seek medical care immediately.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-178-1\" href=\"#footnote-178-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup><\/p>\n<p>Now let&#8217;s take a closer look at the medication grid on epinephrine and norepinephrine in Table 4.15a.<sup><a class=\"footnote\" title=\"This work is a derivative of DailyMed by U.S. National Library of Medicine in the Public Domain.\" id=\"return-footnote-178-2\" href=\"#footnote-178-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<p>Table 4.15a Epinephrine and Norepinephrine Medication Grid<\/p>\n<table class=\"grid\" style=\"height: 244px\">\n<tbody>\n<tr style=\"height: 96px\">\n<th class=\"shaded\" style=\"height: 96px;width: 122.063px\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 154.063px\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 411.063px\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 515.063px\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" style=\"height: 96px;width: 98.0625px\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr style=\"height: 147px\">\n<th style=\"height: 148px;width: 122.063px\" scope=\"row\">Catecholamine<\/th>\n<td style=\"height: 148px;width: 154.063px\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=353f2d30-4b74-43eb-a2ff-26d593d283f8\" target=\"_blank\" rel=\"noopener noreferrer\">epinephrine<\/a><\/p>\n<p><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048\" target=\"_blank\" rel=\"noopener noreferrer\">norepinephrine<\/a><\/td>\n<td style=\"height: 148px;width: 411.063px\">Contraindicated for use in fingers, toes, ears, nose, or genitalia when used with local anesthetic<\/p>\n<p>Monitor vitals (blood pressure, heart rate, respiratory rate) and cardiovascular and respiratory systems closely when administering IV<\/p>\n<p>If administering IV, monitor IV site for extravasation<\/p>\n<p>Discard IV solution if discolored<\/td>\n<td style=\"height: 148px;width: 515.063px\">Reversal of severe allergic reaction, bronchodilation, increased blood pressure, cardiac resuscitation, or control of superficial bleeding<\/td>\n<td style=\"height: 148px;width: 98.0625px\">Hypertension<\/p>\n<p>Tachycardia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Dopamine<\/h2>\n<p>Dopamine is another type of catecholamine specifically used to improve perfusion of organs, improve cardiac output, and increase blood pressure. Dopamine has dose-dependent effects on targeted arteries in the kidneys, heart, and brain.<\/p>\n<p><strong>Mechanism of Action:<\/strong> In low doses, dopamine mainly stimulates dopamine receptors and dilates the renal vasculature. Moderate doses of dopamine stimulate beta-receptors for a positive inotropic effect. Higher doses also stimulate alpha-receptors, constricting blood vessels and increasing blood pressure.<\/p>\n<p><strong>Indications:<\/strong> Dopamine is used to treat shock, improve perfusion to vital organs, increase cardiac output, and correct hypotension.<\/p>\n<p><strong>Nursing Considerations:<\/strong> During infusion, frequently monitor blood pressure, cardiac output, urine output, and color and temperature of limbs. Dopamine can worsen cardiac ischemia and worsen chest pain for clients experiencing unstable angina or a myocardial infarction due to increased cardiac demand for oxygen. If urine flow decreases without hypotension, notify provider because dosage may need to be reduced. High doses of dopamine cause vasoconstriction and can cause adverse effects if extravasation occurs. Concurrent alpha- or beta-blockers can antagonize dopamine.<\/p>\n<p><strong>Side Effects\/Adverse Effects: <\/strong>Common side effects include hypotension with low doses (due to vasodilatory effects) and hypertension in higher doses (due to vasoconstriction). Other side effects include tachycardia, palpitations, and dyspnea. Adverse effects include decreased blood flow to the extremities and decreased urine output.<\/p>\n<p><strong>Health Teaching &amp; Health Promotion: <\/strong>Clients should contact their health care provider immediately if experiencing unusual sweating, dizziness, heart palpitations, or chest pain.<\/p>\n<p>Now let&#8217;s take a closer look at the medication grid on dopamine in Table 4.15b.<sup><a class=\"footnote\" title=\"This work is a derivative of DailyMed by U.S. National Library of Medicine in the Public Domain.\" id=\"return-footnote-178-3\" href=\"#footnote-178-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<p>Table 4.15b Dopamine Medication Grid<\/p>\n<table class=\"grid\">\n<tbody>\n<tr>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Class\/Subclass<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Prototype\/Generic<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Nursing Considerations<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Therapeutic Effects<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th scope=\"row\">Catecholamine<\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">dopamine<\/a><\/td>\n<td>During infusion, monitor ECG, blood pressure, cardiac output, chest pain, pulse rate, urine output, and color and temperature of limbs<\/p>\n<p>Check urine output often<\/p>\n<p>Monitor for extravasation. High doses of dopamine cause vasoconstriction and can cause adverse effects if extravasation occurs<\/td>\n<td>Increased blood flow to kidneys causing increased urine output in low doses<\/p>\n<p>Increased cardiac output and elevated blood pressure in moderate to high doses<\/td>\n<td>Hypotension (low doses) or hypertension (high doses)<\/p>\n<p>Tachycardia<\/p>\n<p>Palpitations<\/p>\n<p>Chest pain<\/p>\n<p>Dyspnea<\/p>\n<p>Decreased blood flow to extremities<\/p>\n<p>If urine flow decreases without hypotension, notify provider because dosage may need to be reduced<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-178-1\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-178-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-178-2\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>. <a href=\"#return-footnote-178-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-178-3\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain<\/a>. <a href=\"#return-footnote-178-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_178_636\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_178_636\"><div tabindex=\"-1\"><p>Include norepinephrine, epinephrine and dopamine. Stimulate the adrenergic receptors.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":83,"menu_order":15,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-178","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":140,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":2,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/178\/revisions"}],"predecessor-version":[{"id":750,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/178\/revisions\/750"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/140"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/178\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=178"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=178"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=178"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}